JCB logo
amgmicro.com
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

Published online 5 November 2001. doi:10.1083/jcb1554rr4
This Article
Right arrow Full Text (PDF, 266K)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Alert me to new content in the JCB
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Leslie, M.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Leslie, M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

© The Rockefeller University Press, 0021-9525/2001/11/497-a $5.00
The Journal of Cell Biology, Volume 155, Number 4, November 12, 2001 497-a-497


Research Roundup

To branch or not to branch


Renal budding (left) increases when endostatin is inhibited (right).

Karihaloo/NAS

Anew study identifies a possible new function for endostatin, the potential cancer-killer that checks blood vessel growth.Within the developing kidney, endostatin may help regulate the branching that establishes the network of urine-collecting tubules.

Cells in the ureteric bud divide and change shape to form the plumbing system of the kidney. Because endostatin inhibits blood vessel formation, Lloyd Cantley (Yale University, New Haven, CT) and colleagues suspected that it might also limit the formation of new tubules within the ureteric bud. To find out, they grew ureteric bud tissue in culture, adding exogenous endostatin or blocking endogenous production.

The results were striking. "Endostatin has a profound effect on branching," says Cantley. The authors found that ureteric bud tissue branches excessively if doused with an anti- endostatin antibody. Buds treated with antibody, for instance, sprouted 75% more branches than the control group. By contrast, adding endostatin to the ureteric bud hampers branch formation. Earlier studies had shown that inactivation of glypican-3, a receptor for endostatin as well as heparin-binding growth factors, results in excessive proliferation and branching of the ureteric bud. These studies identified bone morphogenetic protein as one of the possible regulators of branching in the ureteric bud. This paper adds endostatin to the list, Cantley says. He adds that endostatin's role in the kidneys may not be limited to development; it may also help repair injuries. {blacksquare}

Reference:

Karihaloo, A., et al. 2001. Proc. Natl. Acad. Sci. USA. 98:12509–12514.[Abstract/Full Text]



Mitch Leslie

mleslie{at}cybermesa.com


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?



This Article
Right arrow Full Text (PDF, 266K)
Right arrow PPT slides of all figures
Right arrow Alert me when this article is cited
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Alert me to new content in the JCB
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Leslie, M.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Leslie, M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?


  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents